참고문헌
- Amirian ES, Ittmann MM, Scheurer ME (2011). Associations between arachidonic acid metabolism gene polymorphisms and prostate cancer risk. Prostate, 71, 1382-9. https://doi.org/10.1002/pros.21354
- Asting G, Caren H, Andersson M, Lonnroth C, Lagerstedt K, Lundholm K (2011). COX-2 gene expression in colon cancer tissue related to regulating factors and promoter methylation status. BMC Cancer, 11, 1-10. https://doi.org/10.1186/1471-2407-11-1
- Brown JR, DuBois RN (2005). COX-2: a molecular target for colorectal cancer prevention. J Clin Oncol, 23, 2840-55. https://doi.org/10.1200/JCO.2005.09.051
- Cahlin C, Lonnroth C, Arvidsson A, Nordgren S, Lundholm K (2008). Growth associated proteins in tumor cells and stroma related to disease progression of colon cancer accounting for tumor tissue PGE2 content. Int J Oncol, 32, 909-18.
- Callejas NA, Casado M, Diaz-Guerra M (2001). Expression of cyclooxygenase-2 promotes the release of matrix metalloproteinase-2 and -9 in fetal rat hepatocytes. Hepatology, 33, 860-7. https://doi.org/10.1053/jhep.2001.23002
- Campa D, Zienolddiny S, Maggini V, et al (2004). Association of a common polymorphism in the cyclooxygenase 2 gene with risk of non-small cell lung cancer. Carcinogenesis, 25, 229-35.
- Chun KS, Surh Y (2004). Signal transduction pathways regulating cyclooxygenase-2 expression: potential molecular targets for chemoprevention. Biochem Pharmacal, 68, 1089-1100. https://doi.org/10.1016/j.bcp.2004.05.031
- Chun S, Surh J (2014). Cancer chemoprevention targeting cox-2 using dietary phytochemicals, in 'Cancer and Inflammation Mechanisms: Chemical, Biological, and Clinical Aspects' (eds Y. Hiraku, S. Kawanishi and H. Ohshima), John Wiley & Sons, Inc., Hoooken, NJ, USA.
- Church RD, Fleshman JW, McLeod HL (2003). Cyclooxygenase 2 inhibition in colorectal cancer therapy. Br J Surg, 90, 1055-67. https://doi.org/10.1002/bjs.4297
- Chan AT, Ogino S, Fuchs CS (2007). Aspirin and the risk of colorectal cancer in relation to the expression of COX -2. N Engl J Med, 356, 2131-42. https://doi.org/10.1056/NEJMoa067208
- Cheng I, Liu X, Plummer SJ, et al (2007). COX2 genetic variation, NSAIDs, and advanced prostate cancer risk. Br J Cancer, 97, 557-61. https://doi.org/10.1038/sj.bjc.6603874
- Chulada PC, Thompson MB, Mahler JF (2000). Genetic disruption of Ptgs-l, as well as Ptgs-2, reduces intestinal tumorigenesis in Min mice. Cancer Res, 60, 4705-8.
- Decock J, Paridaens R, Ye S (2008). Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Clin Genet, 73, 197-211.
- Dossus L, Kaaks R, Canzian F, et al (2010). PTGS2 and IL6 genetic variation and risk of breast and protate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3). Carcinogenesis, 31, 455-61 https://doi.org/10.1093/carcin/bgp307
- Eberhart CE, Coffey RJ, Radhika A, et al (1994). Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-8. https://doi.org/10.1016/0016-5085(94)90246-1
- Ekambaram P, Lambiv W, Cazzolli R,Ashton W, Honn V (2011). The thromboxane synthase and receptor signaling pathway in cancer: an emerging paradigm in cancer progression and metastasis. Cancer and Metastasis Reviews, 30, 397-408. https://doi.org/10.1007/s10555-011-9297-9
- Fradet V, Cheng I, Casey G, Witte JS (2009). Dietary omega-3 fatty acids, cyclooxygenase-2 genetic variation, and aggressive prostate cancer risk. Clin Cancer Res, 15, 2559-66. https://doi.org/10.1158/1078-0432.CCR-08-2503
- Greenhough A, Smartt HJ, Moore AE, et al (2009): The COX-2/PGE2 pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment. Carcinogenesis, 30,377-86. https://doi.org/10.1093/carcin/bgp014
- Gustafsson A, Hansson E, Kressner U, et al (2007). EPl-4 subtype, COX and PPAR gamma receptor expression in colorectal cancer in prediction of disease-specific mortality. Int J Cancer, 121, 232-40. https://doi.org/10.1002/ijc.22582
- Gustafsson A, Hansson E, Kressner U, et al (2007). Prostanoid receptor expression in colorectal cancer related to tumor stage, differentiation and progression. Acta Oncol, 56, 1-6.
- Hull MA, Ko SC, Hawcroft G (2004). Prostaglandin EP receptors: targets for treatment and prevention of colorectal cancer? Mol Cancer Ther, 3,1031-39. https://doi.org/10.4161/cbt.3.10.1227
- Hua H, Li M, Luo T, Yin Y, Jiang Y (2011). Matrix metalloproteinases in tumorigenesis: an evolving paradigm. Cellular and Molecular Life Sciences, 68, 3853-68. https://doi.org/10.1007/s00018-011-0763-x
- Kessenbrock K, Plaks V, Werb Z (2010). Matrix metalloproteinases: regulators of the tumor microenvironment. Cell, 141, 52-67. https://doi.org/10.1016/j.cell.2010.03.015
- Lacchini, R, Jacob-Ferreira AL, Luizon MR, et al (2012). Common matrix metalloproteinase 2 gene haplotypes may modulate left ventricular remodelling in hypertensive patients. J Hum Hypertens, 26,171-7. https://doi.org/10.1038/jhh.2011.8
- Langsenlelmer U, Yazdani-Biuki B, Eder T, et al (2006). The cyclooxygenase-2 (PIGS2) 8473T >C polymorphism is associated with breast cancer risk. Clin Cancer Res, 12, 1392-4. https://doi.org/10.1158/1078-0432.CCR-05-2055
- Markowitz SD (2007). Aspirin and colon cancer-targeting prevention? N Engl J Med, 356, 2195-8.
- Masferrer JL, Leahy KM, KokiAT, et al (2006). Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors. Cancer Res, 60, 1306-11.
- Menter DG, Schilsky RL, DuBois RN (2010). Cyclooxygenase-2 and cancer treatment: understanding the risk should be worth the reward. Clin Cancer Res, 16, 1384-90. https://doi.org/10.1158/1078-0432.CCR-09-0788
- Oshima M, Dinchuk JE, Kargman SL (1996). Suppression of intestinal polyposis in Apc delta716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87, 803-9. https://doi.org/10.1016/S0092-8674(00)81988-1
- Oshima H, Oshima M, Inaba K (2004). Hyperplastic gastric tumours induced by activated macrophages in COX-2/mPGES-1 transgenic mice. EMBO J, 23,1669-78. https://doi.org/10.1038/sj.emboj.7600170
- Ozhan G, Lochan R, Leathart JBS, Charnley R, Daly AK (2011). Cyclooxygenase-2 polymorphisms and pancreatic cancer susceptibility. Pancreas, 40, 1289-94. https://doi.org/10.1097/MPA.0b013e31821fcc3b
- Pereira C, Medeiros RM, Dinis-Ribeiro MJ (2009). Cyclooxygenase polymorphisms in gastric and colorectal carcinogenesis: are conclusive results available? Eur J Gastroenterol Hepatol, 21, 76-91. https://doi.org/10.1097/MEG.0b013e32830ce7ba
- Papafili A, Hill MR, Brull DJ, McAnulty RJ, Marshall RP, Humphries SE (2002). Common promoter variant in cyclooxygenase-2 represses gene expression: evidence of role in acute-phase inflammatory response. Arterioscler Thromb Vasc BioI, 22, 1631-36. https://doi.org/10.1161/01.ATV.0000030340.80207.C5
- Price SJ, Greaves DR, Watkins H (2001). Identification of novel, functional genetic variants in the human matrix metalloproteinase-2 gene: role of Sp1 in allele-specific transcriptional regulation. J BioI Chem, 276, 7549-58. https://doi.org/10.1074/jbc.M010242200
- Ruud J, Nilsson A, Ruud L, Wang W, et al (2013). Cancerinduced anorexia in tumor-bearing mice is dependent on cyclooxygenase-1. Brain Behav Immun, 29, 124-35. https://doi.org/10.1016/j.bbi.2012.12.020
- Sanger F, Nicklen S, Coulson AR (1977). DNA sequencing with chain terminating inhibitors. Proc Natl Acad Sci U S A, 74, 5463-7, https://doi.org/10.1073/pnas.74.12.5463
- Shahedi K, Lindstrom S, Zheng SL, et al (2006). Genetic variation in the COX-2 gene and the association with prostate cancer risk. Int J Cancer, 119, 668-72 https://doi.org/10.1002/ijc.21864
- Siironen P, Ristimaki A, Nordling S (2004). Expression of COX-2 is increased with age in papillary thyroid cancer. Histopathology, 44, 490-7. https://doi.org/10.1111/j.1365-2559.2004.01880
- Sivula A, Talvensaari-Mattila A, Lundin J (2005). Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer. Breast Cancer Res Treat, 89, 215-20, https://doi.org/10.1007/s10549-004-0714-4
- Song F, Wang L, HuangY, et al (2013). MiR-21 upregulation induced by promoter zone histone acetylation is associated with chemoresistance to gemcitabine and enhanced malignancy of pancreatic cancer cells. Asian Pac J Cancer Prev, 14, 7529-36, https://doi.org/10.7314/APJCP.2013.14.12.7529
- Thiel A, Narko K., Heinonen M, HemmesA, Tomasetto C, Rio MC, Ristimaki A (2012). Inhibition of cyclooxygenase-2 causes regression of gastric adenomas in trefoil factor 1 deficient mice. Int J Cancer, 131, 1032-41. https://doi.org/10.1002/ijc.27331
- Tsatsanis C, Androulidaki A, Venihaki M, Margioris AN (2006). Signalling networks regulating cyclooxygenase-2. Int J Biochem Cell BioI, 38, 1654-61. https://doi.org/10.1016/j.biocel.2006.03.021
- Tsujii M, Kawano S, DuBois RN (1997). Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA, 94, 3336-40 https://doi.org/10.1073/pnas.94.7.3336
- Wang X, Fu X, Brown PD, Crimmin MJ (1995). Foffman RM. Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in a nude mice. Cancer Res, 54, 4726-8.
- Wang D, Dubois RN (2006). Prostaglandins and cancer. Gut, 55, 115-22. https://doi.org/10.1136/gut.2004.047100
- Wastson SA, Morriss TM, Robinson G, et al (1995). Inhibition of organ invasion by the matrix metalloproteinase inhibitor BB-94 (batimastat) in two human colon carcinoma metastasis models. Cancer Res, 55, 3629-33.
- Waston SA, Morriss TM, Parsons SL, Steele RJC, Brown PD (1996). Therapeutic effect of matrix metalloproteinase inhibitor, batimastat, in a human colorectal cancer ascites model. Br J Cancer, 74, 1354-8. https://doi.org/10.1038/bjc.1996.549
- Wu HC, Chang CH, Ke HL, et al (2011). Association of cyclooxygenase 2 polymorphic genotypes with prostate cancer in Taiwan. Anticancer Res, 31, 221-25.
- Wu CY, Wang CJ, Tseng CC (2005). Helicobacter pylori promote gastric cancer cells invasion through a NF-kappaB and COX-2-mediated pathway, World J Gastroenterol, 11, 3197-203. https://doi.org/10.3748/wjg.v11.i21.3197
- Xu E, Lai M, Lv B, et al (2004). A single nucleotide polymorphism in the matrix metalloproteinase-2 promoter is associated with colorectal cancer. Biochem Biophys Res Commun, 324, 999-1003. https://doi.org/10.1016/j.bbrc.2004.09.150
- Zervos EE, Norman JG, Gower WR, Franz MG, Rosemurgy AS (1997). Matrix metalloproteinase inhibition attenuates human pancreatic cancer growth in vitro and decreases mortality and tumorigenesis in vivo. J Sur Res, 69, 367-71. https://doi.org/10.1006/jsre.1997.5086
- Zhang X, Miao X, Tan W, et al (2005). Identification offunctional genetic variants in cyclooxygenase-2 and their association with risk of esophageal cancer. Gastroenterology, 129, 565-76,
- Zhao F, Zhu H, Huang M, Yi C, Huang Y (2013), The 765G> C polymorphism in the cyclooxygenase-2 gene and gastric cancer risk: an update by meta-analysis. Asian Pac J Cancer Prev, 15, 2863-8. https://doi.org/10.7314/APJCP.2014.15.6.2863
피인용 문헌
- Expression of Cyclooxygenase-2 (COX-2) in Colorectal Adenocarcinoma: an Immunohistochemical and Histopathological Study vol.15, pp.16, 2014, https://doi.org/10.7314/APJCP.2014.15.16.6787
- Matrix Metalloproteinase-2 -1306 C>T Gene Polymorphism is Associated with Reduced Risk of Cancer: a Meta-analysis vol.16, pp.3, 2015, https://doi.org/10.7314/APJCP.2015.16.3.889
- Cyclooxygenase-2 Expression in Invasive Breast Carcinomas of No Special Type and Correlation with Pathological Profiles Suggest a Role in Tumorigenesis Rather than Cancer Progression vol.16, pp.4, 2015, https://doi.org/10.7314/APJCP.2015.16.4.1553
- Cyclooxygenase 2 (rs2745557) Polymorphism and the Susceptibility to Benign Prostate Hyperplasia and Prostate Cancer in Egyptians vol.54, pp.3, 2016, https://doi.org/10.1007/s10528-016-9722-4
- -Catenin Signaling Pathway vol.2017, pp.1741-4288, 2017, https://doi.org/10.1155/2017/3039450
- POLYMORPHISM OF THE COX-2 GENE AND SUSCEPTIBILITY TO COLON AND RECTAL CANCER vol.30, pp.2, 2017, https://doi.org/10.1590/0102-6720201700020008
- USP39 promotes colorectal cancer growth and metastasis through the Wnt/β-catenin pathway vol.37, pp.4, 2017, https://doi.org/10.3892/or.2017.5454
- Effects of gene polymorphisms of metabolic enzymes on the association between red and processed meat consumption and the development of colon cancer; a literature review vol.7, pp.2048-6790, 2018, https://doi.org/10.1017/jns.2018.17
- Colonic Mucosal Microbiota in Colorectal Cancer: A Single-Center Metagenomic Study in Saudi Arabia vol.2018, pp.1687-630X, 2018, https://doi.org/10.1155/2018/5284754